What is the share price of Park Medi World Ltd (PARKHOSPS) today?
The share price of PARKHOSPS as on 22nd May 2026 is ₹259.19. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Park Medi World Ltd (PARKHOSPS) share?
The past returns of Park Medi World Ltd (PARKHOSPS) share are- Past 1 week: 4.92%
- Past 1 month: 15.11%
- Past 3 months: 40.58%
- Past 6 months: 75.19%
- Past 1 year: 75.19%
- Past 3 years: N/A%
- Past 5 years: 75.19%
What are the peers or stocks similar to Park Medi World Ltd (PARKHOSPS)?
The peers or stocks similar to Park Medi World Ltd (PARKHOSPS) include:What is the market cap of Park Medi World Ltd (PARKHOSPS) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Park Medi World Ltd (PARKHOSPS) is ₹11195.22 Cr as of 22nd May 2026.What is the 52 week high and low of Park Medi World Ltd (PARKHOSPS) share?
The 52-week high of Park Medi World Ltd (PARKHOSPS) is ₹266.80 and the 52-week low is ₹138.10.What is the PE and PB ratio of Park Medi World Ltd (PARKHOSPS) stock?
The P/E (price-to-earnings) ratio of Park Medi World Ltd (PARKHOSPS) is 43.37. The P/B (price-to-book) ratio is 9.94.Which sector does Park Medi World Ltd (PARKHOSPS) belong to?
Park Medi World Ltd (PARKHOSPS) belongs to the Health Care sector & Hospitals & Diagnostic Centres sub-sector.How to buy Park Medi World Ltd (PARKHOSPS) shares?
You can directly buy Park Medi World Ltd (PARKHOSPS) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Park Medi World Ltd
PARKHOSPS Share Price
NSEPARKHOSPS Stock Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
PARKHOSPS Performance & Key Metrics
PARKHOSPS Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 44.15 | 9.94 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 42.25 | 6.29 | 0.45% |
from 1 analyst
Price Upside
Earnings Growth
Rev. Growth
PARKHOSPS Company Profile
Park Medi World Ltd operates a chain of over 13 NABH-accredited multi-specialty hospitals in North India, offering more than 30 super specialty and specialty medical services including cardiology, neurology, urology, gastroenterology, oncology, and various surgical disciplines.
PARKHOSPS Sentiment Analysis
PARKHOSPS Sentiment Analysis
PARKHOSPS Stock Summary · February 2026
During its inaugural earnings call, the company showcased a strong commitment to accessible and affordable healthcare, emphasizing strategic expansion in high-potential regions like Uttar Pradesh, where it aims to significantly increase bed capacity. Management expressed confidence in future growth, supported by a proactive approach to operational efficiency and cost management, including a focus on advanced medical technologies and a low capital expenditure strategy. Despite challenges in staffing new facilities, the company is poised to enhance its service offerings, particularly in high-end medical procedures, while maintaining strong financial metrics, including an EBITDA margin of 27%. The recent CGHS rate hikes are expected to bolster revenue, reflecting a positive market sentiment and a strategic shift towards a more diverse payer mix, ultimately positioning the company for sustained success in the evolving healthcare landscape.
PARKHOSPS Stock Growth Drivers
PARKHOSPS Stock Growth Drivers
9Commitment to Quality Healthcare
Park Medi World Limited has established itself as a leader in the healthcare sector since
Operational Efficiency and Growth
The company has achieved significant operational efficiencies, with an average occupancy rate of approximately 65%
PARKHOSPS Stock Challenges
PARKHOSPS Stock Challenges
2Cautious Financial Projections
The management has indicated that the recent CGHS rate hike, which ranges from 12% to
Employee Cost Management Challenges
The company is facing challenges in managing employee costs, particularly concerning full-time doctors. Although they
PARKHOSPS Forecast
PARKHOSPS Forecasts
Price
Revenue
Earnings
PARKHOSPS Share Price Forecast
PARKHOSPS Share Price Forecast
All values in ₹
All values in ₹
PARKHOSPS Company Revenue Forecast
PARKHOSPS Company Revenue Forecast
All values in ₹ Thousand cr.
All values in ₹ Thousand cr.
PARKHOSPS Stock EPS (Earnings Per Share) Forecast
PARKHOSPS Stock EPS (Earnings Per Share) Forecast
All values in ₹
All values in ₹
PARKHOSPS
PARKHOSPS
Income
Balance Sheet
Cash Flow
PARKHOSPS Income Statement
PARKHOSPS Income Statement
| Quarter | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | mar 2026 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 362.89 | 362.49 | 405.16 | 418.23 | 419.07 | 467.92 | ||||||
| Operating & Other expenses | 265.32 | 265.49 | 294.06 | 297.46 | 310.56 | 333.05 | ||||||
| EBITDA | 97.57 | 97.00 | 111.10 | 120.77 | 108.51 | 134.87 | ||||||
| Depreciation/Amortization | 15.03 | 15.53 | 13.43 | 14.89 | 15.30 | 17.51 | ||||||
| PBIT | 82.54 | 81.47 | 97.67 | 105.88 | 93.21 | 117.36 | ||||||
| Interest & Other Items | 15.73 | 15.65 | 15.13 | 14.53 | 14.95 | 13.98 | ||||||
| PBT | 66.81 | 65.82 | 82.54 | 91.35 | 78.26 | 103.38 | ||||||
| Taxes & Other Items | 21.22 | 21.00 | 24.09 | 17.79 | 27.52 | 32.53 | ||||||
| Net Income | 45.59 | 44.82 | 58.45 | 73.56 | 50.74 | 70.85 | ||||||
| EPS | 1.19 | 1.36 | 1.52 | 2.04 | 1.35 | 1.78 |
PARKHOSPS Company Updates
Investor Presentation
PARKHOSPS Stock Peers
PARKHOSPS Past Performance & Peer Comparison
PARKHOSPS Past Performance & Peer Comparison
Health CareHospitals & Diagnostic Centres
Valuation
Technical
Forecast
| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Park Medi World Ltd | 43.37 | 9.94 | — |
| Apollo Hospitals Enterprise Ltd | 61.93 | 10.83 | 0.24% |
| Max Healthcare Institute Ltd | 69.04 | 10.62 | 0.20% |
| Fortis Healthcare Ltd | 69.60 | 7.91 | 0.10% |
PARKHOSPS Stock Price Comparison
Compare PARKHOSPS with any stock or ETFPARKHOSPS Holdings
PARKHOSPS Shareholdings
PARKHOSPS Promoter Holdings Trend
PARKHOSPS Promoter Holdings Trend
PARKHOSPS Institutional Holdings Trend
PARKHOSPS Institutional Holdings Trend
In last 3 months, retail holding in the company has decreased by 1.40%
In last 3 months, foreign institutional holding of the company has almost stayed constant
PARKHOSPS Shareholding Pattern
PARKHOSPS Shareholding Pattern
PARKHOSPS Shareholding History
PARKHOSPS Shareholding History
Mutual Funds Invested in PARKHOSPS
Mutual Funds Invested in PARKHOSPS
No mutual funds holding trends are available
Top 5 Mutual Funds holding Park Medi World Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 1.8672% | Percentage of the fund’s portfolio invested in the stock 1.55% | Change in the portfolio weight of the stock over the last 3 months 0.18% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 20/103 (+3) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.7939% | Percentage of the fund’s portfolio invested in the stock 1.90% | Change in the portfolio weight of the stock over the last 3 months 0.44% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 37/68 (+5) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.5148% | Percentage of the fund’s portfolio invested in the stock 0.94% | Change in the portfolio weight of the stock over the last 3 months 0.25% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 46/60 (+2) |
Compare 3-month MF holding change on Screener
smallcases containing PARKHOSPS stock
smallcases containing PARKHOSPS stock
Looks like this stock is not in any smallcase yet.
PARKHOSPS Events
PARKHOSPS Events
PARKHOSPS Dividend Trend
PARKHOSPS has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
PARKHOSPS Dividend Trend
PARKHOSPS has not given any dividends in last 5 years
PARKHOSPS Dividends
PARKHOSPS Dividends
PARKHOSPS Stock News & Opinions
PARKHOSPS Stock News & Opinions
Net profit of Park Medi World rose 58.03% to Rs 70.86 crore in the quarter ended March 2026 as against Rs 44.84 crore during the previous quarter ended March 2025. Sales rose 30.09% to Rs 460.41 crore in the quarter ended March 2026 as against Rs 353.92 crore during the previous quarter ended March 2025. For the full year,net profit rose 28.01% to Rs 258.12 crore in the year ended March 2026 as against Rs 201.64 crore during the previous year ended March 2025. Sales rose 20.51% to Rs 1679.36 crore in the year ended March 2026 as against Rs 1393.57 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales460.41353.92 30 1679.361393.57 21 OPM %27.6624.99 -26.4626.62 - PBDT120.9081.36 49 417.05342.57 22 PBT103.3965.83 57 354.58285.67 24 NP70.8644.84 58 258.12201.64 28 Powered by Capital Market - Live
Park Medi World will hold a meeting of the Board of Directors of the Company on 12 May 2026.
The newly launched facility is aimed at strengthening access to tertiary and quaternary care across the Tricity region, covering Haryana, Punjab, Himachal Pradesh, and Chandigarh. The move is expected to reduce dependence on metro cities such as Delhi for advanced treatments. The Panchkula hospital is equipped with advanced diagnostics, modular operation theatres, and critical care infrastructure. It will offer services across major specialties including oncology, neurosciences, orthopedics, cardiology, and robotic-assisted procedures, with a significant focus on high-acuity and critical care. The launch comes alongside the ongoing expansion of the company's Mohali facility, further scaling its regional presence. With this, the group's combined capacity in the Tricity region is expected to reach around 850 beds. Park Group currently operates 16 hospitals with a total capacity of 3,960 beds. The company is also in the process of adding five more hospitals and expanding existing facilities, which is expected to increase total capacity to 5,460 beds by March 2028. On a consolidated basis, net profit of Park Medi World rose 11.38% to Rs 50.78 while net sales rose 17.76% to Rs 409.97 crore in Q3 December 2025 over Q3 December 2024.
Park Group of Hospitals has today launched advanced multi-super specialty hospital in Panchkula, alongside the ongoing expansion of its Mohali facility, strengthening access to advanced healthcare across the Tricity region. The hospital has been developed to address the growing demand for tertiary and quaternary care services across Haryana, Punjab, Himachal Pradesh, and Chandigarh. By bringing high-end medical care closer to patients, the hospital aims to reduce dependence on metro cities such as Delhi for advanced treatments. The Panchkula hospital is equipped with advanced diagnostics, modular operation theatres, critical care infrastructure, and will deliver comprehensive care across key specialties including oncology, neurosciences, orthopedics, cardiology, and critical care including robotic-assisted procedures. Designed with a strong focus on high-acuity care, a significant proportion of beds are dedicated to critical care services.
Park Medi World set to launch Panchkula Hospital on 10 April 2026 instead of previously announced 29 March 2026. Powered by Capital Market - Live
The board of Park Medi World at its meeting held on 10 March 2026 has approved the launch of a multispecialty hospital at Panchkula on 29 March 2026. The board also approved the addition of bed capacity y of Grecian Super Speciality Hospital, Mohali (Mohali Hospital) by adding 150 beds to the existing bed capacity of 350 beds. The Mohali Hospital is run and operated by RGS Healthcare, subsidiary of the company. Powered by Capital Market - Live
Net profit of Park Medi World rose 11.38% to Rs 50.78 crore in the quarter ended December 2025 as against Rs 45.59 crore during the previous quarter ended December 2024. Sales rose 17.76% to Rs 409.97 crore in the quarter ended December 2025 as against Rs 348.13 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales409.97348.13 18 OPM %24.2523.78 - PBDT93.5781.83 14 PBT78.2766.81 17 NP50.7845.59 11 Powered by Capital Market - Live
Park Medi World will hold a meeting of the Board of Directors of the Company on 28 January 2026.Powered by Capital Market - Live
The board of Park Medi World at its meeting held on 05 January 2026 has approved the acquisition of whole of existing shareholding of Krishna Super-speciality Hospital which owns and operates Mahip Hospitals for a consideration of Rs 40 crore. Strategically positioned in the heart of Bathinda, Krishna Super-speciality Hospital serves as a vital healthcare hub for both urban and rural districts, offering a centralized location for multiple super-specialties. Park Medi World has been managing operations of Krishna Super-speciality Hospital since July 2025, and has now acquired 100% shareholding from the current promoters. With the addition of this hospital, Park Group increases its hospital capacity and strengthens its infrastructure, supporting its plan to reach a total of 5,260 beds by March 2028.Powered by Capital Market - Live
The board of Park Medi World at its meeting held on 19 December 2025 has approved the acquisition of 100% stake in KP Institute of Medical Sciences (KPIMS), Agra, Uttar Pradesh, in an all-cash transaction amounting Rs 245 crore. Since its launch in 2023, KPIMS has become a prominent multi-specialty provider for Agra and neighbouring areas being one of the biggest healthcare facilities in the region. Upon consummation of the acquisition, KPIMS will be a 360 beded multi super speciality hospital. Its NABH accreditation, comprehensive super-specialty services, and inclusion in major insurance and government schemes, position KPIMS strongly for sustained market growth. Powered by Capital Market - Live
Pledged promoter holdings is insignificant